Technology
Transgenomic licenses new oligonucleotide synthesis technology from University of Calgary
Published in Gene Therapy Weekly, June 20th, 2002
The technology, invented by Dr. Richard T. Pon of the University of Calgary, was licensed through University Technologies International, Inc., of Calgary, Alberta, Canada (UTI).
Current oligo synthesis starts with a solid support, a foundation on which to build the oligo, preloaded with a linker and the first nucleic acid base. The linker couples the first base to the foundation and can be cleaved, or cut, at the end of the building process to remove the foundation from the finished oligo. Other...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
Source: Gene Therapy Weekly (2002-06-20)
More Articles from Gene Therapy Weekly
- Gene Distribution
Scintigraphic imaging validates efficacy of gene delivery systems - Ovarian Cancer
Fiber modification enables viral vectors to skirt receptor deficiency - Anthrax
Genetically altered anthrax antigen shows promise as next-generation vaccine component - Gene Stimulation
Angiogenic gene therapy could be used for treating number of disorders - Hepatocellular Carcinoma
VP22-mediated trafficking leads to heightened apoptosis in liver cancer - Diabetic Retinopathy
Angiopoietin-1 reverses leukocyte adhesion in retinas of diabetic model - More from this issue of Gene Therapy Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
